Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JAMP RALOXIFENE DIN 02540681

Status: Marketed
Holder: JAMP PHARMA CORPORATION
Molecule: RALOXIFENE HYDROCHLORIDE
Available to quote

Health Canada record

Active ingredient(s)RALOXIFENE HYDROCHLORIDE 60 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCG03XC01 RALOXIFENE
Original market date28-Jun-2024
Current status date28-Jun-2024
SourceHealth Canada DPD

Establishment licence of the holder

Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RALOXIFENE HYDROCHLORIDE

DINProductCompanyFormStrengthStatus
02358840ACT RALOXIFENETEVA CANADA LIMITEDTabletRALOXIFENE HYDROCHLORIDE 60 MGMarketed
02279215APO-RALOXIFENEAPOTEX INCTabletRALOXIFENE HYDROCHLORIDE 60 MGMarketed
02239028EVISTAELI LILLY CANADA INCTabletRALOXIFENE HYDROCHLORIDE 60 MGCancelled Post Market
02358921PMS-RALOXIFENEPHARMASCIENCE INCTabletRALOXIFENE HYDROCHLORIDE 60 MGCancelled Post Market
02415852RALOXIFENEPRO DOC LIMITEETabletRALOXIFENE HYDROCHLORIDE 60 MGCancelled Post Market
02312298TEVA-RALOXIFENETEVA CANADA LIMITEDTabletRALOXIFENE HYDROCHLORIDE 60 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
315592023-09-06Abbreviated New Drug Submission (ANDS)

International API supply for RALOXIFENE HYDROCHLORIDE

10 valid EDQM Certificates of Suitability from 10 holders. 14 active FDA Drug Master Files.

Request a quote for JAMP RALOXIFENE

How to read a Canadian DIN record